Jasper Therapeutics, Inc. (JSPR) Ownership

$2.49

north_east
$0.07 (2.89%)
Day's range
$2.4
Day's range
$2.53

Jasper Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VELAN CAPITAL INVESTMENT MANAGEMENT LP 11/14/2025 2.67 M $6.21 M   86.10% 17.76%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 1.49 M $3.56 M   0.00% 9.95%
ACORN CAPITAL ADVISORS, LLC 11/17/2025 1.38 M $3.29 M   100.00% 9.20%
KINGDON CAPITAL MANAGEMENT, L.L.C. 11/14/2025 1.32 M $3.15 M   93.49% 8.82%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2025 1.10 M $2.62 M   101.90% 7.33%
CARLYLE GROUP INC. 11/07/2025 1.07 M $2.53 M   0.00% 7.10%
WOODLINE PARTNERS LP 11/14/2025 1.04 M $2.47 M   100.00% 6.92%
VANGUARD GROUP INC 11/07/2025 1.03 M $2.46 M   65.36% 6.88%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/14/2025 1.03 M $2.45 M   46.21% 6.85%
PROPEL BIO MANAGEMENT, LLC 11/12/2025 1.03 M $2.45 M   100.00% 6.85%
QIMING U.S. VENTURES MANAGEMENT, LLC 11/10/2025 928.96 K $2.21 M   0.00% 6.18%
MORGAN STANLEY 11/14/2025 789.96 K $1.88 M   2.63% 5.26%
SPHERA FUNDS MANAGEMENT LTD. 11/14/2025 629.47 K $1.50 M   4,190.57% 4.19%
SIMPLIFY ASSET MANAGEMENT INC. 10/20/2025 609.05 K $1.45 M   100.00% 4.05%
CITADEL ADVISORS LLC 11/14/2025 589.45 K $1.40 M   43.61% 3.92%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2025 442.64 K $1.05 M   100.00% 2.95%
LION POINT CAPITAL, LP 11/14/2025 398.56 K $948.57 K   172.05% 2.65%
MILLENNIUM MANAGEMENT LLC 11/14/2025 364.94 K $868.56 K   151.30% 2.43%
ARMISTICE CAPITAL, LLC 11/17/2025 348.00 K $828.24 K   100.00% 2.32%
BANK OF AMERICA CORP /DE/ 11/14/2025 294.55 K $701.04 K   0.37% 1.96%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 208.50 K $496.23 K   1,904.81% 1.39%
BLACKROCK, INC. 11/12/2025 204.93 K $487.74 K   -9.16% 1.36%
KNOTT DAVID M JR 11/12/2025 171.39 K $407.91 K   100.00% 1.14%
DEUTSCHE BANK AG\ 11/13/2025 160.00 K $380.80 K   0.00% 1.07%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 130.86 K $311.56 K   -0.21% 0.87%
BANK OF MONTREAL /CAN/ 11/13/2025 111.80 K $266.09 K   -29.30% 0.74%
READYSTATE ASSET MANAGEMENT LP 11/07/2025 98.44 K $234.29 K   100.00% 0.66%
IEQ CAPITAL, LLC 11/14/2025 48.12 K $114.52 K   100.00% 0.32%
STATE STREET CORP 11/14/2025 44.70 K $106.38 K   -0.12% 0.30%
CITADEL ADVISORS LLC 11/14/2025 44.50 K $105.91 K   100.00% 0.30%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 41.69 K $99.65 K   4,880.53% 0.28%
TWO SIGMA INVESTMENTS, LP 11/14/2025 40.43 K $96.22 K   100.00% 0.27%
UBS GROUP AG 11/13/2025 39.35 K $93.66 K   -90.55% 0.26%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 38.96 K $92.73 K   -12.76% 0.26%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 35.59 K $84.71 K   -41.54% 0.24%
NORTHERN TRUST CORP 11/14/2025 33.91 K $80.71 K   -2.85% 0.23%
GOLDMAN SACHS GROUP INC 11/14/2025 26.89 K $64.00 K   -89.24% 0.18%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 26.10 K $62.12 K   -7.45% 0.17%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 25.90 K $61.64 K   -27.65% 0.17%
IKARIAN CAPITAL, LLC 11/14/2025 25.11 K $59.75 K   0.00% 0.17%
VOLEON CAPITAL MANAGEMENT LP 11/14/2025 20.95 K $49.86 K   100.00% 0.14%
STONEPINE CAPITAL MANAGEMENT, LLC 11/13/2025 20.20 K $48.08 K   100.00% 0.13%
GROUP ONE TRADING, L.P. 11/12/2025 17.55 K $41.77 K   100.00% 0.12%
CITADEL ADVISORS LLC 11/14/2025 17.40 K $41.41 K   -0.57% 0.12%
SQUAREPOINT OPS LLC 11/14/2025 13.96 K $33.23 K   -44.99% 0.09%
SEQUENT PLANNING LLC 11/12/2025 12.50 K $29.75 K   19.05% 0.08%
MARINER, LLC 11/14/2025 12.19 K $29.02 K   -52.21% 0.08%
FMR LLC 11/13/2025 11.90 K $28.32 K   -36.90% 0.08%
SOWELL FINANCIAL SERVICES LLC 10/17/2025 10.40 K $24.75 K   -39.89% 0.07%
CREWE ADVISORS LLC 11/13/2025 3.10 K $7.38 K   0.00% 0.02%

Jasper Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 85 institutional investors and hedge funds held shares of Jasper Therapeutics, Inc.. The most heavily invested institutionals were:

Velan Capital Investment Management LP: 2.67 M

Soleus Capital Management, L.P.: 1.49 M

ACORN CAPITAL ADVISORS, LLC: 1.38 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 1.32 M

Rock Springs Capital Management LP: 1.1 M

Carlyle Group Inc.: 1.07 M

134.17% of Jasper Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 27.18 M shares in the last 24 months. This purchase volume represents approximately $67.68 M in transactions.